Haemonetics Corporation
HAE
$53.12
-$0.62-1.15%
NYSE
| 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 163.34M | 167.68M | 130.07M | 123.81M | 114.89M |
| Total Depreciation and Amortization | 108.51M | 108.89M | 106.42M | 100.92M | 94.86M |
| Total Amortization of Deferred Charges | 6.70M | 6.70M | 8.60M | 8.60M | 8.60M |
| Total Other Non-Cash Items | 22.86M | -3.18M | 10.93M | 14.89M | 18.87M |
| Change in Net Operating Assets | -74.86M | -98.36M | -126.76M | -163.29M | -101.98M |
| Cash from Operations | 226.54M | 181.73M | 129.25M | 84.94M | 135.24M |
| Capital Expenditure | -33.17M | -35.07M | -26.11M | -21.44M | -34.12M |
| Sale of Property, Plant, and Equipment | 3.19M | 23.25M | 21.35M | 21.44M | 21.77M |
| Cash Acquisitions | -1.76M | -150.91M | -150.91M | -394.76M | -393.00M |
| Divestitures | 43.29M | 43.29M | 1.50M | 1.50M | 1.50M |
| Other Investing Activities | -67.26M | -42.47M | -38.83M | -51.30M | -42.47M |
| Cash from Investing | -55.70M | -161.90M | -192.99M | -444.56M | -446.33M |
| Total Debt Issued | 0.00 | 950.00M | 950.00M | 1.06B | 1.06B |
| Total Debt Repaid | 83.51M | -502.69M | -564.63M | -566.56M | -658.26M |
| Issuance of Common Stock | 7.87M | 8.33M | 8.30M | 7.68M | 8.12M |
| Repurchase of Common Stock | -230.27M | -235.24M | -85.24M | -84.84M | -14.15M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -88.42M | -111.58M | -111.67M | -111.46M | -23.26M |
| Cash from Financing | -227.32M | 108.82M | 196.77M | 304.82M | 372.45M |
| Foreign Exchange rate Adjustments | 4.94M | -685.00K | -6.16M | 3.08M | -2.66M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.53M | 127.96M | 126.87M | -51.72M | 58.71M |